Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $10.08 Analyst target: $14.44 Upside: 43.25%
Novavax, Inc., a biotechnology company, focuses on the discovery, development and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company is headquartered in Gaithersburg, Maryland.
See the full interactive analysis & chart →Informational only — not investment advice.